Has David Jacofsky received payments from drug or device companies?

Yes. Drug and device makers reported $11,305,175 in general payments to David Jacofsky across 318 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Jacofsky did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Jacofsky come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Jacofsky

Surgical Oncology · Phoenix, AZNPI 1922040179

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $10,462,687 of the $11,305,175 with a category attached, or 92.5%. Stryker accounts for 95.5% of it on its own, with 8 other manufacturers making up the rest. Among surgical oncology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,305,175in general payments, 2019–2025

Across 318 payments — averaging $35,551 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$10.8M
Johnson & Johnson$503K
Smith+Nephew$610
Surgalign Spine Technologies, Inc.$90
Crossroads Extremity Systems, LLC$84
Biocomposites Inc$50
plus $91 from 3 others

$2,142in research payments, 2019–2025

Across 4 payments — averaging $535.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Stryker$2K

What the payments were for

Royalty or licence$10,462,68793%
Consulting fees$263,9472%
Travel & lodging$66,8671%
Food & beverage$8,2140%
Other$503,4614%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	303	$10,800,789
Johnson & Johnson	1	$503,461
Smith+Nephew	7	$610
Surgalign Spine Technologies, Inc.	1	$90
Crossroads Extremity Systems, LLC	1	$84
Biocomposites Inc	1	$50
Boston Scientific	2	$39
Onkos Surgical, Inc.	1	$37
My01 Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,305,175 in reported general payments places this provider in the 95th percentile of 29 surgical oncology providers in Arizona.

See all surgical oncology providers in Arizona →

Other surgical oncology in Phoenix

Dipak RamkumarPhoenix$148K
Zhi Ven FongPhoenix$7K
Zeynep AydiPhoenix$4K
William CancePhoenix$2K
Jason WisemanPhoenix$96
Mark GimbelGilbert$14K
Taylor RiallTucson$6K
Rohit SahaiChandler$5K
Sivakami MoorthyGlendale$5K
Mohammad KhreissTucson$3K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →